0001209191-21-008080.txt : 20210205
0001209191-21-008080.hdr.sgml : 20210205
20210205163735
ACCESSION NUMBER: 0001209191-21-008080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210205
DATE AS OF CHANGE: 20210205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celebi John
CENTRAL INDEX KEY: 0001843539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39980
FILM NUMBER: 21596242
MAIL ADDRESS:
STREET 1: SENSEI BIOTHERAPEUTICS, INC.
STREET 2: 1405 RESEARCH BLVD., STE. 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sensei Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001829802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 PROFESSIONAL DRIVE
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: (240) 243-8000
MAIL ADDRESS:
STREET 1: 620 PROFESSIONAL DRIVE
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-03
0
0001829802
Sensei Biotherapeutics, Inc.
SNSE
0001843539
Celebi John
C/O SENSEI BIOTHERAPEUTICS, INC.
1405 RESEARCH BLVD, SUITE 125
ROCKVILLE
MD
20850
1
1
0
0
President & CEO
Stock Option (Right to Buy)
19.00
2021-02-03
4
A
0
416666
0.00
A
2031-02-02
Common Stock
416666
416666
D
One-fourth (1/4th) of the options granted hereby shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, February 3, 2021, thereafter one forty-eighth (1/48th) of the options granted shall vest and become exercisable each month following the Vesting Commencement Date, over four years such that the options shall be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the grantee's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each such vesting date.
/s/ Mark Ballantyne (Attorney-in-Fact)
2021-02-05